COSCIENS Biopharma Statistics
Total Valuation
CSCI has a market cap or net worth of $10.98 million. The enterprise value is -$1.07 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSCI has 3.15 million shares outstanding. The number of shares has increased by 57.27% in one year.
| Current Share Class | 3.15M |
| Shares Outstanding | 3.15M |
| Shares Change (YoY) | +57.27% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| Forward PS | n/a |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.88 |
| Quick Ratio | 2.21 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -86.36 |
Financial Efficiency
Return on equity (ROE) is -151.97% and return on invested capital (ROIC) is -57.41%.
| Return on Equity (ROE) | -151.97% |
| Return on Assets (ROA) | -23.33% |
| Return on Invested Capital (ROIC) | -57.41% |
| Return on Capital Employed (ROCE) | -48.77% |
| Revenue Per Employee | $225,750 |
| Profits Per Employee | -$439,075 |
| Employee Count | 40 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 3.78 |
Taxes
In the past 12 months, CSCI has paid $496,000 in taxes.
| Income Tax | 496,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.12% in the last 52 weeks. The beta is 1.86, so CSCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.86 |
| 52-Week Price Change | -67.12% |
| 50-Day Moving Average | 3.21 |
| 200-Day Moving Average | 3.39 |
| Relative Strength Index (RSI) | 48.89 |
| Average Volume (20 Days) | 3,439 |
Short Selling Information
The latest short interest is 22,703, so 0.72% of the outstanding shares have been sold short.
| Short Interest | 22,703 |
| Short Previous Month | 24,858 |
| Short % of Shares Out | 0.72% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 5.37 |
Income Statement
In the last 12 months, CSCI had revenue of $9.03 million and -$17.56 million in losses. Loss per share was -$6.04.
| Revenue | 9.03M |
| Gross Profit | 4.27M |
| Operating Income | -11.75M |
| Pretax Income | -18.05M |
| Net Income | -17.56M |
| EBITDA | -10.52M |
| EBIT | -11.75M |
| Loss Per Share | -$6.04 |
Full Income StatementBalance Sheet
The company has $13.76 million in cash and $2.23 million in debt, giving a net cash position of $11.53 million or $3.66 per share.
| Cash & Cash Equivalents | 13.76M |
| Total Debt | 2.23M |
| Net Cash | 11.53M |
| Net Cash Per Share | $3.66 |
| Equity (Book Value) | 10.14M |
| Book Value Per Share | 3.22 |
| Working Capital | 13.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.07 million and capital expenditures -$1.21 million, giving a free cash flow of -$15.28 million.
| Operating Cash Flow | -14.07M |
| Capital Expenditures | -1.21M |
| Free Cash Flow | -15.28M |
| FCF Per Share | -$4.86 |
Full Cash Flow StatementMargins
Gross margin is 47.26%, with operating and profit margins of -130.07% and -194.50%.
| Gross Margin | 47.26% |
| Operating Margin | -130.07% |
| Pretax Margin | -189.00% |
| Profit Margin | -194.50% |
| EBITDA Margin | -116.45% |
| EBIT Margin | -130.07% |
| FCF Margin | n/a |